ConductScience.org, home

Paper108388

Rhodotorulic acid--investigation of its potential as an iron-chelating drug.

Grady RW and 8 others. J Pharmacol Exp Ther, 1979. Cited by 30 papers, by iCite.

Cite this record

ConductScience Library. Rhodotorulic acid--investigation of its potential as an iron-chelating drug. Papers, record 108388. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/108388

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Rhodotorulic acid--investigation of its potential as an iron-chelating drug.
PubMed
Journal
J Pharmacol Exp Ther
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
30
iCite
Relative citation ratio, by iCite
1.48
iCite
Revised in PubMed
2019-12-10
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Grady RWR W
2Peterson CMC M
3Jones RLR L
4Graziano JHJ H
5Bhargava KKK K
6Berdoukas VAV A
7Kokkini GG
8Loukopoulos DD
9Cerami AA

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hydroxamic AcidsMajor topic
Iron Chelating AgentsMajor topic
PiperazinesMajor topic
Adult
Animals
Deferoxamine
Dogs
Female
Haplorhini
Humans
Hydroxybenzoates
Infusions, Parenteral
Injections, Intramuscular
Iron
Macaca fascicularis
Male
Mice
Rats
Rhodotorula
Thalassemia

Source PubMed

Download CSV of topics

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.

PMIDTitleJournalYearIn PapersSource
38069073Drug Selection and Posology, Optimal Therapies and Risk/Benefit Assessment in Medicine: The Paradigm of Iron-Chelating Drugs.Int J Mol Sci2023https://conductscience.org/library/papers/38069073PubMed
35049961Biosynthesis Pathways, Transport Mechanisms and Biotechnological Applications of Fungal Siderophores.J Fungi (Basel)2021https://conductscience.org/library/papers/35049961PubMed
8262586Present status and future prospects of oral iron chelation therapy in thalassaemia and other diseases.Indian J Pediatr1993https://conductscience.org/library/papers/8262586PubMed
3122880Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.Br Med J (Clin Res Ed)1987https://conductscience.org/library/papers/3122880PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/108388

GET https://conductscience.org/api/papers/v1/108388/authors